Domov › Atopični dermatitis (ekcem) › South Carolina
Klinične študije za Atopični dermatitis (ekcem) v South Carolina
10 študij za Atopični dermatitis (ekcem) išče udeležence na lokacijah v South Carolina.
Mesta v South Carolina
Uradno besedilo študije (angleško)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Advanced Dermatology and Cosmetic Surgery - Spartanburg- Site Number : 8400004, Spartanburg
Vključevanje udeležencevOpazovalna študija
Starost 12 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07290803A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Medical University of South Carolina - South Carolina Translational Research Nexus Clinic, Charleston
- Tribe Clinical Research, LLC, Greenville
Vključevanje udeležencevFaza 3
Starost 2–11 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06807281First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
- National Allergy and Asthma Research, LLC, North Charleston
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
Starost 18–65 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07527923A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Charleston
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07003425A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 12, Anderson
Vključevanje udeležencevFaza 2
Starost 18–74 · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT07037901A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Medical University of South Carolina /ID# 265113, Charleston
Vključevanje udeležencevFaza 3
Starost 2–11 · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT06461897A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, Charleston
Vključevanje udeležencevFaza 3
6 Months – 11 Years · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT06311682A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Medical University of South Carolina /ID# 263655, Charleston
- Advanced Dermatology And Cosmetic Surgery - Spartanburg /ID# 267185, Spartanburg
Vključevanje udeležencevFaza 3
Starost 18–63 · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT06389136A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- National Allergy and Asthma, North Charleston
- Spartanburg Medical Research, Spartanburg
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 4. maj 2026 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7106, Bluffton
Vključevanje udeležencevOpazovalna študija
Starost 12 in več · Vsi spoli · Posodobljeno 13. mar. 2026 · NCT06988605Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.